Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation
Bo‐Zong Shao, Shuling Wang, Peng Pan, et al.
Inflammation (2019) Vol. 42, Iss. 4, pp. 1147-1159
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

NLRP3 Inflammasome and Inflammatory Diseases
Zheng Wang, Simei Zhang, Ying Xiao, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 277
Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota
Siyuan Sun, Xiuxiu Xu, Ling Liang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 144
Role of NLRP3 inflammasome in inflammatory bowel diseases
Evanthia Tourkochristou, Ιωάννα Αγγελετοπούλου, Christos Konstantakis, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 33, pp. 4796-4804
Open Access | Times Cited: 84
Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
Ya-Shuo Feng, Zixuan Tan, Manman Wang, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 76
Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments
Yaxi Zhou, Diandian Wang, Wenjie Yan
Nutrients (2023) Vol. 15, Iss. 4, pp. 1031-1031
Open Access | Times Cited: 36
Pulsatilla chinensis saponins improve SCFAs regulating GPR43-NLRP3 signaling pathway in the treatment of ulcerative colitis
Zexie Li, Yonggui Song, Weize Xu, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116215-116215
Closed Access | Times Cited: 23
Formononetin ameliorates DSS-induced colitis by inhibiting the MAPK/PPAR-γ/NF-κB/ROS signaling pathways
Shen Cao, Baojiang Lv, Tai Yi, et al.
Toxicology and Applied Pharmacology (2025), pp. 117239-117239
Closed Access | Times Cited: 1
Protective effect and mechanism of polysaccharide from Dictyophora indusiata on dextran sodium sulfate-induced colitis in C57BL/6 mice
Yalin Wang, Xingming Ji, Meilin Yan, et al.
International Journal of Biological Macromolecules (2019) Vol. 140, pp. 973-984
Closed Access | Times Cited: 64
The Role of Autophagy in Inflammatory Bowel Disease
Bo‐Zong Shao, Yi Yao, Junshan Zhai, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 55
Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease
Yijie Song, Yuge Zhao, Yueming Ma, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 60, pp. 61-75
Closed Access | Times Cited: 50
Covalent Targeting As a Common Mechanism for Inhibiting NLRP3 Inflammasome Assembly
Caroline Stanton, Jie Sun, Kayla Nutsch, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 2, pp. 254-265
Open Access | Times Cited: 6
Curcumin attenuates aflatoxin B1-induced ileum injury in ducks by inhibiting NLRP3 inflammasome and regulating TLR4/NF-κB signaling pathway
Hang Pan, Ting Hu, Ying He, et al.
Mycotoxin Research (2024) Vol. 40, Iss. 2, pp. 255-268
Closed Access | Times Cited: 6
Atractylenolide I Alleviates Indomethacin-Induced Gastric Ulcers in Rats by Inhibiting NLRP3 Inflammasome Activation
Chengzhi Yuan, Chang Yu, Qifang Sun, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 25, pp. 14165-14176
Closed Access | Times Cited: 6
Ameliorative Effect of Sinapic Acid on Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in Kunming (KM) Mice
Bo Qian, Chengqiang Wang, Zhen Zeng, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 42
Therapeutic implications of inflammasome in inflammatory bowel disease
Vishal Khatri, Ramaswamy Kalyanasundaram
The FASEB Journal (2021) Vol. 35, Iss. 5
Open Access | Times Cited: 37
Activation of AMPK/mTOR-driven autophagy and inhibition of NLRP3 inflammasome by saxagliptin ameliorate ethanol-induced gastric mucosal damage
Hany H. Arab, Ahmed M. Ashour, Amany M. Gad, et al.
Life Sciences (2021) Vol. 280, pp. 119743-119743
Closed Access | Times Cited: 35
The Role of Neutrophil Extracellular Traps in Cancer
Bo‐Zong Shao, Yi Yao, Jin‐Ping Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 35
Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases
Nadire Özenver, Thomas Efferth
Pharmacological Research (2021) Vol. 170, pp. 105710-105710
Closed Access | Times Cited: 34
Albiflorin ameliorates inflammation and oxidative stress by regulating the NF-κB/NLRP3 pathway in Methotrexate-induced enteritis
Haihua Zhang, Jing Wang, Wuying Lang, et al.
International Immunopharmacology (2022) Vol. 109, pp. 108824-108824
Closed Access | Times Cited: 26
Medicinal Plants, Phytochemicals and Regulation of the NLRP3 Inflammasome in Inflammatory Bowel Diseases: A Comprehensive Review
Rosa Direito, Sandra Maria Barbalho, Maria Eduardo Figueira, et al.
Metabolites (2023) Vol. 13, Iss. 6, pp. 728-728
Open Access | Times Cited: 16
Helminth-derived biomacromolecules as therapeutic agents for treating inflammatory and infectious diseases: What lessons do we get from recent findings?
Pritha Chakraborty, Vivekanandhan Aravindhan, Suprabhat Mukherjee
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124649-124649
Closed Access | Times Cited: 13
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
Pengfei Chen, Xia Li
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets
Hayandra F. Nanini, Cláudio Bernardazzi, Fernando Castro, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 41, pp. 4622-4634
Open Access | Times Cited: 40
Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development—A Focus on Ulcerative Colitis
Iuliana Samoilă, Sorina Dinescu, Marieta Costache
Cells (2020) Vol. 9, Iss. 7, pp. 1647-1647
Open Access | Times Cited: 37
Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology
Luca Maroni, Elisabetta Ninfole, Claudio Pinto, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 736-736
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top